Table 1

The concentrations of growth factors (GF) and interleukins (ILs) in cord blood serum (CBS) and peripheral blood serum (PBS) treatments, administered to patients in this study. Values are expressed as pg/mL/day, except for PDGF * ng/mL/day. CBS treatment delivered higher content of both GFS and ILs as compared with PBS, with the exception of IGF1 and IGF2

Median95% CIMedian95% CI
EGF237.50195.17 to 272.50130.00114.53 to 140.40
FGF122.00117.69 to 133.0025.3010.76 to 42.57
IGF10.000.00 to 0.003.300.00 to 9.52
IGF24.253.56 to 5.4423.9519.36 to 29.08
NGF1.481.20 to 1.571.301.19 to 1.58
PDGF*2.041.79 to 2.361.291.19 to 1.37
IL-1-β24.553.40 to 72.270.510.41 to 0.65
IL-40.270.18 to 0.370.180.090 to 0.27
IL-649.684.59 to 340.544.492.03 to 11.85
IL-102.402.27 to 2.731.961.80 to 2.52
IL-1367.7958.85 to 85.080.0800.00 to 0.37
TGF-α14.2211.57 to 15.964.043.10 to 4.86
VEGF81.5033.14 to 134.5836.6031.20 to 42.64
  • EGF, epidermal growth factor; FGF, fibroblast growth factor; IGF, insulin growth factor; NGF, nerve growth factor; PDGF, platelet-derived GF; TGF, transforming growth factor.